Favarel-Garrigues J F, Sztark F, Petitjean M E, Thicoïpé M, Lassié P, Dabadie P
Department of Emergency, Pellegrin University Hospital, Bordeaux, France.
Anesth Analg. 1996 Feb;82(2):312-6. doi: 10.1097/00000539-199602000-00017.
Sixty elderly patients (> 70 yr old) undergoing surgery for hip fracture were prospectively studied in order to compare hemodynamic tolerance of titrated doses of hyperbaric bupivacaine using continuous spinal anesthesia (CSA) versus single-dose spinal anesthesia (SDSA). Patients were randomized into two groups (CSA group: n = 30; SDSA group: n = 30). The SDSA patients received 10-15 mg of 0.5% hyperbaric bupivacaine (based on age and height), and the CSA patients received a starting dose of 5 mg of 0.5% hyperbaric bupivacaine, followed after 15 min by optional reinjection of 2.5 mg every 5 min until a T10 level sensory block was reached. Onset of anesthesia, noninvasive hemodynamic variables and the need for ephedrine were studied for 4 h after induction of anesthesia. Spinal anesthesia was successful in all patients. Decreases in mean arterial pressure were significantly less frequent and less pronounced in the CSA group (19.9% +/- 1.6% of the baseline value) than in the SDSA group (40.2% +/- 1.9%, P < 0.0001). The mean dose of ephedrine was significantly less in the CSA group (1.8 +/- 0.7 mg, administered to only 37% of patients) than in the SDSA group (19.4 +/- 3.3 mg administered to all patients, P < 0.0001). No late complications related to the spinal anesthesia technique were observed in either group. We concluded that CSA, using small titrated doses of 0.5% hyperbaric bupivacaine, is safe, efficient, and provides better hemodynamic stability than SDSA in elderly patients.
为比较持续蛛网膜下腔麻醉(CSA)与单次蛛网膜下腔麻醉(SDSA)下,不同滴定剂量的高压布比卡因的血流动力学耐受性,我们对60例接受髋部骨折手术的老年患者(年龄>70岁)进行了前瞻性研究。患者被随机分为两组(CSA组:n = 30;SDSA组:n = 30)。SDSA组患者接受10 - 15mg 0.5%高压布比卡因(根据年龄和身高),CSA组患者接受起始剂量5mg 0.5%高压布比卡因,15分钟后可选择每5分钟追加2.5mg,直至达到T10感觉阻滞平面。麻醉诱导后4小时,观察麻醉起效时间、无创血流动力学变量及麻黄碱的使用需求。所有患者蛛网膜下腔麻醉均成功。CSA组平均动脉压下降的频率和幅度显著低于SDSA组(分别为基础值的19.9%±1.6%和40.2%±1.9%,P < 0.0001)。CSA组麻黄碱的平均用量显著低于SDSA组(分别为1.8±0.7mg,仅37%的患者使用;19.4±3.3mg,所有患者均使用,P < 0.0001)。两组均未观察到与蛛网膜下腔麻醉技术相关的晚期并发症。我们得出结论,对于老年患者,使用小剂量滴定的0.5%高压布比卡因的CSA安全、有效,且比SDSA能提供更好的血流动力学稳定性。